Suven Life Sciences Limited
NSE:SUVEN.NS
128.96 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 116.929 | 135.392 | 118.443 | 134.783 | 144.147 | 6,453.49 | 6,125.822 | 5,435.317 | 4,995.224 | 5,208.55 | 5,103.124 | 2,578.846 | 2,042.079 | 1,504.339 | 1,293.116 | 1,408.32 | 1,199.811 | 1,132.622 | 901.112 | 662.4 |
| Cost of Revenue
| 317.726 | 5.656 | 24.326 | 1.031 | 0.227 | 2,733.473 | 2,419.171 | 2,389.215 | 2,408.622 | 2,451.694 | 1,904.093 | 1,217.258 | 1,024.865 | 763.257 | 588.912 | 674.12 | 605.554 | 550.939 | 417.622 | 293.155 |
| Gross Profit
| -200.797 | 129.736 | 94.117 | 133.752 | 143.92 | 3,720.017 | 3,706.651 | 3,046.102 | 2,586.602 | 2,756.856 | 3,199.031 | 1,361.588 | 1,017.214 | 741.082 | 704.204 | 734.2 | 594.257 | 581.683 | 483.49 | 369.246 |
| Gross Profit Ratio
| -1.717 | 0.958 | 0.795 | 0.992 | 0.998 | 0.576 | 0.605 | 0.56 | 0.518 | 0.529 | 0.627 | 0.528 | 0.498 | 0.493 | 0.545 | 0.521 | 0.495 | 0.514 | 0.537 | 0.557 |
| Reseach & Development Expenses
| 1,144.272 | 1,153.51 | 1,063.675 | 710.273 | 1,032.264 | 1,086.57 | 796.869 | 991.454 | 911.283 | 559.626 | 479.479 | 346.933 | 330.491 | 311.435 | 341.507 | 294.604 | 201.686 | 190.016 | 195.671 | 117.874 |
| General & Administrative Expenses
| 27.107 | 25.346 | 24.941 | 22.87 | 9.756 | 120.424 | 103.056 | 26.831 | 75.902 | 185.375 | 75.265 | 263.202 | 226.954 | 118.283 | 112.565 | 114.83 | 0.431 | 8.662 | 70.008 | 55.759 |
| Selling & Marketing Expenses
| 162.768 | 0 | 0 | 0 | 0 | 85.075 | 51.114 | 31.845 | 39.637 | 51.741 | 67.122 | 15.229 | 0 | 0 | 0 | 0 | 20.632 | 21.496 | 15.84 | 21.717 |
| SG&A
| 189.875 | 25.346 | 24.941 | 22.87 | 9.756 | 205.499 | 154.17 | 26.831 | 115.539 | 237.116 | 510.651 | 278.431 | 226.954 | 118.283 | 112.565 | 114.83 | 21.063 | 30.158 | 85.848 | 77.476 |
| Other Expenses
| 211.3 | 84.49 | 0.13 | 77.537 | 296.929 | 3.303 | 0.529 | 1,008.954 | 0.894 | 481.933 | 617.34 | 561.471 | 269.258 | 214.747 | 160.557 | 67.494 | 288.396 | 237.891 | 128.642 | 118.235 |
| Operating Expenses
| 1,144.272 | 1,459.669 | 1,379.225 | 966.438 | 1,337.856 | 2,334.234 | 1,934.916 | 2,027.239 | 1,749.764 | 1,278.675 | 1,096.819 | 908.404 | 826.703 | 644.465 | 614.629 | 550.357 | 511.145 | 458.065 | 410.161 | 313.585 |
| Operating Income
| -1,345.069 | -1,319.157 | -1,262.164 | -832.845 | -1,194.656 | 1,385.783 | 1,771.735 | 1,018.863 | 836.838 | 1,478.181 | 2,102.212 | 453.184 | 190.511 | 96.617 | 89.575 | 183.843 | 83.113 | 123.618 | 73.329 | 55.661 |
| Operating Income Ratio
| -11.503 | -9.743 | -10.656 | -6.179 | -8.288 | 0.215 | 0.289 | 0.187 | 0.168 | 0.284 | 0.412 | 0.176 | 0.093 | 0.064 | 0.069 | 0.131 | 0.069 | 0.109 | 0.081 | 0.084 |
| Total Other Income Expenses Net
| 284.282 | 136.479 | 42.213 | 58.105 | 130.648 | 201.649 | 183.524 | 211.842 | 85.523 | 37.366 | -74.833 | -124.66 | -99.093 | -64.073 | -52.519 | -132.876 | -19.522 | -16.065 | -8.382 | 4.482 |
| Income Before Tax
| -1,060.787 | -1,182.678 | -1,219.951 | -774.74 | -1,064.008 | 1,587.432 | 1,955.259 | 1,230.705 | 922.361 | 1,515.547 | 2,027.379 | 328.524 | 91.418 | 32.544 | 37.056 | 50.967 | 63.59 | 107.554 | 64.947 | 60.143 |
| Income Before Tax Ratio
| -9.072 | -8.735 | -10.3 | -5.748 | -7.381 | 0.246 | 0.319 | 0.226 | 0.185 | 0.291 | 0.397 | 0.127 | 0.045 | 0.022 | 0.029 | 0.036 | 0.053 | 0.095 | 0.072 | 0.091 |
| Income Tax Expense
| -10.024 | 86.535 | 15.976 | -53.228 | -121.829 | 718.001 | 718.384 | 358.832 | 254.975 | 428.044 | 585.804 | 20.129 | -52.206 | -71.451 | -32.95 | -20.255 | -19.941 | -5.089 | 1.073 | 36.083 |
| Net Income
| -1,050.763 | -1,182.678 | -1,219.951 | -721.512 | -942.179 | 869.431 | 1,236.875 | 871.873 | 667.386 | 1,087.503 | 1,441.575 | 308.395 | 143.624 | 103.995 | 70.006 | 71.222 | 83.531 | 112.643 | 63.873 | 24.06 |
| Net Income Ratio
| -8.986 | -8.735 | -10.3 | -5.353 | -6.536 | 0.135 | 0.202 | 0.16 | 0.134 | 0.209 | 0.282 | 0.12 | 0.07 | 0.069 | 0.054 | 0.051 | 0.07 | 0.099 | 0.071 | 0.036 |
| EPS
| -6.66 | -7.5 | -7.73 | -4.57 | -5.97 | 5.51 | 8.95 | 6.31 | 5.17 | 8.33 | 11.37 | 2.43 | 1.13 | 0.81 | 0.55 | 0.57 | 0.66 | 0.9 | 2.35 | 0.22 |
| EPS Diluted
| -6.64 | -7.47 | -7.71 | -4.56 | -5.95 | 5.5 | 8.95 | 6.31 | 5.17 | 8.33 | 11.37 | 2.43 | 1.13 | 0.81 | 0.55 | 0.57 | 0.66 | 0.9 | 2.35 | 0.22 |
| EBITDA
| -1,280.047 | -1,174.355 | -1,210.551 | -723.667 | -1,022.471 | 1,654.666 | 2,049.252 | 1,342.207 | 1,087.715 | 1,785.077 | 2,217.064 | 557.836 | 275.964 | 175.675 | 166.547 | 196.265 | 170.87 | 171.4 | 124.763 | 104.465 |
| EBITDA Ratio
| -10.947 | -8.674 | -10.221 | -5.369 | -7.093 | 0.256 | 0.335 | 0.247 | 0.218 | 0.343 | 0.434 | 0.216 | 0.135 | 0.117 | 0.129 | 0.139 | 0.142 | 0.151 | 0.138 | 0.158 |